Internal Med Medical News about Hypogonadism Male Gels Testosterone

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

5. Rapid correction of low vitamin D status in nursing home residents

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Safety and efficacy of testosterone gel in the treatment of male hypogonadism
Clinical Interventions in Aging, 10/12/09

Lakshman M et al. – Testosterone gels are as efficacious as patches and injectable forms in their effects on sexual function and mood. Anticipated increases in prostate–specific antigen with testosterone therapy are not significantly different with testosterone gels, and the risk of polycythemia is ower than injectable modalities. Application site reactions, a major drawback of testosterone patches, occur less frequently with testosterone gels. However, inter–personal transfer is a concern if appropriate precautions are not taken. Superior tolerability and dose flexibility make testosterone gel highly desirable over other modalities of testosterone replacement. Androgel and Testim, the two currently available testosterone gel products in the US, have certain brandspecific properties that clinicians may consider prior to prescribing.

<< Previous
The Association of Endogenous Sex Hormones, Adiposity, and...

Next >>
Phase I/II Study of Concurrent Chemoradiotherapy for Localized...

Trough serum testosterone predicts the development of polycythemia in hypogonadal men treated for up to 21 years with subcutaneous testosterone pellets
European Journal of Endocrinology, 11/17/09 Relevance Score: 67%

Hypogonadism Risk in Men Treated for Childhood Cancer
Internet Source, 11/05/09 Relevance Score: 67%

Is androgen therapy indicated for aging men?
Sexuality, Reproduction & Menopause, 10/05/09 Relevance Score: 67%

Do male lymphoma survivors have impaired sexual function?
Journal of Clinical Oncology, 10/29/09 Relevance Score: 66%

Hypogonadism Risk in Men Treated for Childhood Cancer
Journal of Clinical Endocrinology and Metabolism, 10/12/09 Relevance Score: 66%